Sol-Gel Technologies SLGL
NASDAQ SLGL
$69.96 -0.14 (-0.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sol-Gel Technologies (SLGL) Retained Earnings (2015 - 2026)

Sol-Gel Technologies (SLGL) posted quarterly Retained Earnings of -$240.7 million for Q1 2026, little changed year-over-year from -$241.8 million in Q1 2025, and down 1.57% quarter-over-quarter from -$237.0 million in Q4 2025.

Analysis

Sol-Gel Technologies (SLGL) Retained Earnings (2015 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has reported Retained Earnings for 11 consecutive years, with -$240.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Retained Earnings changed 0.44% year-over-year to -$240.7 million; the TTM figure through Mar 2026 stood at -$240.7 million (changed 0.44% YoY), while the FY2025 annual figure was -$237.0 million, down 2.65% from the prior year.
  • Retained Earnings slipped to -$240.7 million in Q1 2026 per SLGL's latest filing, from -$237.0 million in the prior quarter.
  • Across five years, Retained Earnings topped out at -$183.7 million in Q1 2022 and bottomed at -$240.7 million in Q1 2026.
  • Historically, Retained Earnings has averaged -$218.2 million across 5 years, with a median of -$224.7 million in 2024.
  • Annual changes were most pronounced in 2022 — Retained Earnings rose 2.55% — and 2023, when it declined 15.05%.
  • Sol-Gel Technologies' Retained Earnings stood at -$193.1 million in 2022, then dropped by 14.11% to -$220.3 million in 2023, then declined by 4.8% to -$230.9 million in 2024, then decreased by 2.65% to -$237.0 million in 2025, then declined by 1.57% to -$240.7 million in 2026.
  • Business Quant data shows SLGL's Retained Earnings at -$240.7 million in Q1 2026, -$237.0 million in Q4 2025, and -$234.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 15.69 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 37.62 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 558.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.10 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -4.00 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 13.05 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -6.33 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 4.38 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.57 Bn
10 Sol-Gel Technologies 194.01 Mn 146.08 Mn - -244.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -244.42 Mn
Mar 31, 2026 -240.74 Mn
Dec 31, 2025 -237.01 Mn
Sep 30, 2025 -234.02 Mn
Jun 30, 2025 -228.08 Mn
Mar 31, 2025 -239.69 Mn
Dec 31, 2024 -230.88 Mn
Sep 30, 2024 -225.04 Mn
Jun 30, 2024 -224.67 Mn
Mar 31, 2024 -226.65 Mn
Dec 31, 2023 -220.30 Mn
Sep 30, 2023 -215.47 Mn
Jun 30, 2023 -209.76 Mn
Mar 31, 2023 -203.33 Mn
Dec 31, 2022 -193.07 Mn
Sep 30, 2022 -187.28 Mn
Jun 30, 2022 -209.76 Mn
Mar 31, 2022 -183.74 Mn
Dec 31, 2021 -178.14 Mn
Sep 30, 2021 -192.17 Mn